Michael W. Freeman

Stock Analyst at Raymond James

(1.57)
# 3,517
Out of 5,043 analysts
45
Total ratings
29.4%
Success rate
-0.2%
Average return

Stocks Rated by Michael W. Freeman

Profound Medical Corp.
Aug 7, 2026
Reiterated: Buy
Price Target: n/a
Current: $9.83
Upside: -
Vitalhub Corp.
Aug 7, 2026
Reiterated: Buy
Price Target: n/a
Current: $7.20
Upside: -
WELL Health Technologies Corp.
Aug 7, 2026
Reiterated: Buy
Price Target: n/a
Current: $4.14
Upside: -
Apotex Health Corp.
Jul 6, 2026
Initiated Coverage: Buy
Price Target: $36.00
Current: $30.79
Upside: +16.92%
Healwell AI Inc.
Mar 25, 2026
Reiterated: Buy
Price Target: $3.00 → $2.50
Current: $0.74
Upside: +237.84%
HLS Therapeutics Inc.
Nov 18, 2025
Reiterated: Buy
Price Target: $6.00 → $7.00
Current: $4.09
Upside: +71.15%
Medexus Pharmaceuticals Inc.
Aug 14, 2025
Reiterated: Buy
Price Target: $8.00
Current: $4.95
Upside: n/a
Bausch Health Companies Inc.
Aug 5, 2025
Reiterated: Hold
Price Target: $11.40
Current: $8.64
Upside: n/a
Knight Therapeutics Inc.
Mar 12, 2025
Reiterated: Buy
Price Target: $8.00
Current: $10.83
Upside: n/a
Perimeter Medical Imaging AI, Inc.
Nov 18, 2024
Upgraded: Buy
Price Target: $1.50
Current: $0.22
Upside: n/a